2018-06-20

[#DIV28SUPER] APA Div28 2018 Convention Details

 

Dear APA Division 28 Members,

 

The 126th annual APA meeting is rapidly approaching (August 9-12, 2018, San Francisco, CA). On behalf of the current APA Division 28 President (Mark Smith) and Program Chair (myself), we are excited to present to you the 2018 Division 28 programming schedule (see attached).

 

Division 28 Program Highlights Include:  

- Multidisciplinary themes and approaches (collaborative programming with 14 other APA divisions, 4 APA groups and 2 NIH divisions)

- Primary and secondary symposia focused on opioids (4), cannabis/marijuana (4), nicotine/tobacco (2), psychedelics (1) and alcohol (1)

- Emphasis on translational and sex differences research

- Two primary symposia sponsored by the APA Central Programming Group focused on emerging clinical and research tools with live demonstrations (non-invasive brain stimulation and data crowdsourcing)

- Two networking/social hours

- Two collaborative poster sessions with Division 50 (addiction), NIDA and NIAAA (>100 posters total)

- Eight opportunities to earn continuing education credits

 

Division 28 is also participating in these special events:

- The APA Social Hour for First-Time Attendees

- The APA Science at Sunset Poster Competition

 

Other important notes:

- The early-bird registration deadline (save up to 20%) is a little over a week away. Register here: http://convention.apa.org/attend/pricing

- Keyword search the entire convention program here: http://www.apa.org/convention/program-search.aspx?_ga=2.5664755.1782418109.1529507864-298983051.1515943711

- Stay connected with this handle: #APA2018

- Stay connected with the APA Convention App (fyi, the reviews for these apps are not stellar but the website keyword search seems legit):

Apple: https://itunes.apple.com/us/app/american-psychological-association/id1007514352?ls=1&mt=8

            Google Play: https://play.google.com/store/apps/details?id=com.coreapps.android.followme.apaconvention

- Visit the main convention website for additional information here: http://convention.apa.org

 

If you have any program-related questions, concerns or comments, then please feel free to email me. We are looking forward to seeing you in San Francisco!

 

Warm regards,

Michael

 

--------------------------------------------------------------------------

Michael J. Wesley, Ph.D.

Program Chair, Psychopharmacology and Substance Abuse

Mark Smith

President, Psychopharmacology and Substance Abuse

 

Assistant Professor and Director

Neurobehavioral Systems Lab

University of Kentucky College of Medicine

Department of Behavioral Science

 

Office: (859) 323-1332

Lab:    (859) 257-7444

 

CONFIDENTIALITY STATEMENT

The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at 859.323.1332 and delete this message and its attachments, if any. 

--------------------------------------------------------------------------

 

2018-06-18

Re: [#DIV28SUPER] Post-Doctoral Fellowship at the University of Kentucky

Hi
May I know how you got my name? 

On Mon, Jun 18, 2018 at 10:55 AM Stoops, William <wwstoo0@email.uky.edu> wrote:

Post-Doctoral Fellowship

** Available July 1, 2018 ***

The Laboratory of Human Behavioral Pharmacology at the University of Kentucky College of Medicine is seeking applicants for a post-doctoral fellowship. This is a two-year fellowship, with an optional third year, funded by the National Institute on Drug Abuse (NIDA) that is designed to train researchers in behavioral pharmacology and clinical trials in the treatment of drug use disorders. The fellowship also provides ample opportunity for professional development, including grant writing and enhancing presentation and publication skills. Applicants should be highly motivated, have recently obtained a doctorate in psychology, pharmacology or a related discipline and must be a U.S. citizen or permanent resident. The fellowship includes salary, tuition (if applicable) and expenses for travel to conferences.  

To Apply: Submit a cover letter stating your research interests along with CV and 3 letters of reference to: william.stoops@uky.edu. The application review begins immediately and will continue until the position is filled. This is a full-time position that is available starting July 1.  

For further inquiries, contact:

-Dr. Joshua A. Lile

Associate Professor, Department of Behavioral Science, University of Kentucky College of Medicine

jalile2@uky.edu

-Dr. Craig R. Rush

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

Crush2@email.uky.edu

-Dr. William W. Stoops

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

William.stoops@uky.edu



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

--
Shirin Tabib, PsyD.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] Post-Doctoral Fellowship at the University of Kentucky

would you please provide me with the application link.
Thanks!

Dr. Ben E. Toubak, DMD,PsyD, MA, MPH. CAADAC
Neuropsychology Consultation,
Lead Learning Disability Specialist Counselor
Drug & Alcohol Counselor
Adjunct Faculty - Lecturer



On Monday, June 18, 2018, 10:55:15 AM PDT, Stoops, William <wwstoo0@EMAIL.UKY.EDU> wrote:


Post-Doctoral Fellowship

** Available July 1, 2018 ***

The Laboratory of Human Behavioral Pharmacology at the University of Kentucky College of Medicine is seeking applicants for a post-doctoral fellowship. This is a two-year fellowship, with an optional third year, funded by the National Institute on Drug Abuse (NIDA) that is designed to train researchers in behavioral pharmacology and clinical trials in the treatment of drug use disorders. The fellowship also provides ample opportunity for professional development, including grant writing and enhancing presentation and publication skills. Applicants should be highly motivated, have recently obtained a doctorate in psychology, pharmacology or a related discipline and must be a U.S. citizen or permanent resident. The fellowship includes salary, tuition (if applicable) and expenses for travel to conferences.  

To Apply: Submit a cover letter stating your research interests along with CV and 3 letters of reference to: william.stoops@uky.edu. The application review begins immediately and will continue until the position is filled. This is a full-time position that is available starting July 1.  

For further inquiries, contact:

-Dr. Joshua A. Lile

Associate Professor, Department of Behavioral Science, University of Kentucky College of Medicine

jalile2@uky.edu

-Dr. Craig R. Rush

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

Crush2@email.uky.edu

-Dr. William W. Stoops

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

William.stoops@uky.edu



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Post-Doctoral Fellowship at the University of Kentucky

Post-Doctoral Fellowship

** Available July 1, 2018 ***

The Laboratory of Human Behavioral Pharmacology at the University of Kentucky College of Medicine is seeking applicants for a post-doctoral fellowship. This is a two-year fellowship, with an optional third year, funded by the National Institute on Drug Abuse (NIDA) that is designed to train researchers in behavioral pharmacology and clinical trials in the treatment of drug use disorders. The fellowship also provides ample opportunity for professional development, including grant writing and enhancing presentation and publication skills. Applicants should be highly motivated, have recently obtained a doctorate in psychology, pharmacology or a related discipline and must be a U.S. citizen or permanent resident. The fellowship includes salary, tuition (if applicable) and expenses for travel to conferences.  

To Apply: Submit a cover letter stating your research interests along with CV and 3 letters of reference to: william.stoops@uky.edu. The application review begins immediately and will continue until the position is filled. This is a full-time position that is available starting July 1.  

For further inquiries, contact:

-Dr. Joshua A. Lile

Associate Professor, Department of Behavioral Science, University of Kentucky College of Medicine

jalile2@uky.edu

-Dr. Craig R. Rush

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

Crush2@email.uky.edu

-Dr. William W. Stoops

Professor, Department of Behavioral Science, University of Kentucky College of Medicine

William.stoops@uky.edu



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2018-06-15

[#DIV28SUPER] Call for Papers

Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue for April 2019 on:

Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids

 

This special issue will provide an overview of current research on cannabis and cannabinoids with an emphasis on issues related to their legalization for medical and recreational use.  We encourage submission of review articles and original research reports in this area, including the following topics: therapeutic efficacy of cannabis and cannabinoids across different disease conditions; etiology of cannabinoid use disorders; consequences of cannabinoid exposure during pregnancy, adolescence, and adulthood; development of forensic testing for detecting acute cannabis intoxication;  influence of route of cannabinoid administration on therapeutic effects and abuse liability;  variations in THC content across cannabis strains and cannabinoid-enriched products, and implications for use; current federal restrictions on cannabis research; prevalence of synthetic cannabinoids, issues with their regulation, mechanisms of action and consequences of their use; and changes in public perceptions of perceived harm of medicinal and recreational cannabis and cannabinoid use.

 

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2018 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft the title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Ashley Acheson, PhD, awacheson@uams.edu, or William Fantegrossi, wefantegrossi@uams.edu, or the Editor, William Stoops, PhD at william.stoops@uky.edu.



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2018-06-13

[#DIV28SUPER] Psychology Graduate study at Univ of Pittsburgh for underrepresented students

The Pitt Psychology Department is excited to announce the second year of our VIPitt program which is a two-day program for prospective graduate students who are racially and/or ethnically underrepresented students who are interested in graduate study and research in Psychology at Pitt. The program will be in October 2018, and the deadline for applications is July 1st, 2018. 

Here’s the link with additional information:

 

https://psychology.pitt.edu/event/vipitt-weekend

 

The application is brief. The program has dual goals of helping students improve applications and interview skills, as well as giving them more information about Pitt in the hopes that they’ll consider applying to work with faculty here for their graduate work. We cover basically everything: travel to Pittsburgh, housing, meals, and transportation to and from the airport both in Pittsburgh and home towns.

 

Ken Perkins PhD

Univ of Pittsburgh

2018-06-11

[#DIV28SUPER] Division 28 Social Happy Hour TONIGHT as Henry's Pub!

Division 28 Members – For those of you attending CPDD, please plan to attend our Social Happy Hour TONIGHT at Henry's Pub, and please advertise, recruit, and bring your non-Division 28 friends and colleagues to join the Division 

 

Social Happy Hour and Bottomless Buffet

 

The Division of Psychopharmacology and Substance Abuse (Division 28) of the American Psychological Association invites our CPDD friends and colleagues interested in the Division to join us for a Social Happy Hour on Monday, June 11, 7:00 - 8:30 pm for drinks and a bottomless buffet.

 

All guests who elect to join the Division will receive two free drink tickets.

 

Henry's Pub

Gaslamp Quarter

(10-min walk from the Hilton)

618 5th Avenue
San Diego, CA 92101

 

The Division of Psychopharmacology and Substance Abuse is a professional organization established in 1966 as a division of the American Psychological Association. Its mission is to advance scientific knowledge and education on general psychopharmacology and the determinants and treatment of substance abuse. Our membership includes individuals from universities, medical schools, hospitals, government, industry, and private practice.

 

Annual membership fees are $20 for members, associates, and affiliates, and $9 for students. All guests who elect to join the Division will receive two free drink tickets ($14 value)